Projects per year
Personal profile
Education/Academic qualification
Infectious Diseases, Clinical Fellowship, University of Texas Health Science Center at Houston
Jul 1 2005 → Jun 1 2007
Award Date: Jun 1 2007
Internal Medicine, Residency, University of Texas Health Science Center at Houston
Jul 1 2003 → Jun 1 2005
Award Date: Jun 1 2005
Internal Medicine, Internship, University of Texas Health Science Center at Houston
Jul 1 2007 → Jun 1 2003
Award Date: Jun 1 2003
MD, University of Texas Health Science Center at Houston
Aug 1 1997 → May 1 2002
Award Date: May 1 2002
Research Area Keywords
- Clinical Care
Fingerprint
Dive into the research topics where Kevin A. Grimes is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A Phase III, adjudicator-blinded, randomised study to evaluate the efficacy and safety of treatment with olorofim versus treatment with AmBisome® followed by standard of care (SOC) in patients with invasive fungal disease (IFD) caused by Aspergillus species
Grimes, K. A., Lin, J., Malik, A. I. & Nigo, M.
11/16/23 → …
Project: Clinical Trial
-
BAT IT: Banked Anti- SARS Cov-2 T cell Infusions for Treatment of COVID-19
10/1/20 → 3/31/22
Project: Non Profit
Research output
- 16 Article
-
Bloodstream infections after solid organ transplantation: clinical epidemiology and antimicrobial resistance (2016–21)
Adelman, M. W., Connor, A. A., Hsu, E., Saharia, A., Mobley, C. M., Victor, D. W., Hobeika, M. J., Lin, J., Grimes, K. A., Ramos, E., Pedroza, C., Brombosz, E. W., Ghobrial, R. M. & Arias, C. A., Feb 1 2024, In: JAC-Antimicrobial Resistance. 6, 1, p. dlad158 158.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials
CORIMUNO-19 Collaborative Group, DisCoVeRy Study Group, ACTT-2 Study Group & ACTT-3 Study Group, Mar 2024, In: EClinicalMedicine. 69, 102472.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Outcomes in solid organ transplant recipients receiving organs from a donor with Fusarium solani species complex meningitis
Griffin, I. S., Smith, D. J., Annambhotla, P., Gold, J. A. W., Ostrosky-Zeichner, L., Kauffman, C. A., Gade, L., Litvintseva, A., Friedman, D. Z. P., Nishio Lucar, A. G., Parpia, T. C., Lieberman, J., Bujan, J., Corkrean, J., Divatia, M. K., Grimes, K., Lin, J., Mobley, C., Schwartz, M. R., Hannawi, B., & 8 others, 2024, (Accepted/In press) In: Transplant Infectious Disease.Research output: Contribution to journal › Article › peer-review
-
Single-center Outcomes After Liver Transplantation With SARS-CoV-2–Positive Donors: An Argument for Increased Utilization
Connor, A. A., Adelman, M. W., Mobley, C. M., Moaddab, M., Erhardt, A. J., Hsu, D. E., Brombosz, E. W., Sanghvi, M., Lee Cheah, Y., Simon, C. J., Hobeika, M. J., Saharia, A. S., Victor, D. W., Kodali, S., Basra, T., Graviss, E. A., Nguyen, D. T., Elsaiey, A., Moore, L. W., Nigo, M., & 6 others, Mar 7 2024, In: Transplantation Direct. 10, 4, p. E1590Research output: Contribution to journal › Article › peer-review
Open Access -
Allogeneic, off-the-shelf, SARS-CoV-2-specific T cells (ALVR109) for the treatment of COVID-19 in high-risk patients
Vasileiou, S., Hill, L. Q., Kuvalekar, M., Workineh, A. G., Watanabe, A., Velazquez, Y., Lulla, S., Mooney, K., Lapteva, N., Grilley, B. J., Heslop, H. E., Rooney, C. M., Brenner, M. K., Eagar, T. N., Carrum, G., Grimes, K. A., Leen, A. M. & Lulla, P., Jul 1 2023, In: Haematologica. 108, 7, p. 1840-1850 11 p.Research output: Contribution to journal › Article › peer-review
Open Access18 Scopus citations